Cargando…
Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease
This pilot study examined the status of the master iron regulatory peptide, hepcidin, and peripheral related iron parameters in Alzheimer’s disease (AD) and mild cognitive impairment patients, and evaluated the relationship between iron dyshomeostasis and amyloid-beta (Aβ), cognitive assessment test...
Autores principales: | Sternberg, Zohara, Hu, Zihua, Sternberg, Daniel, Waseh, Shayan, Quinn, Joseph F., Wild, Katharine, Jeffrey, Kaye, Zhao, Lin, Garrick, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362180/ https://www.ncbi.nlm.nih.gov/pubmed/28400987 http://dx.doi.org/10.14336/AD.2016.0811 |
Ejemplares similares
-
Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
por: Masaldan, Shashank, et al.
Publicado: (2019) -
Activation of the Hepcidin-Ferroportin1 pathway in the brain and astrocytic–neuronal crosstalk to counteract iron dyshomeostasis during aging
por: Mezzanotte, Mariarosa, et al.
Publicado: (2022) -
Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?
por: Wang, Feixue, et al.
Publicado: (2022) -
Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases
por: Mariani, S., et al.
Publicado: (2013) -
The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)